Pre-operative Evaluation Of Prostate Cancer By Positron Emission Tomography/Computed Tomography (Pet-ct) With Psma-68ga: Correlation With Prostate Magnetic …
C Stasiak, A Cardillo, SA de Almeida, DB Parente… - 2021 - Soc Nuclear Med
1335 Introduction: PET-CT image with Gallium-68 is a non-invasive diagnostic method to
assess the biological behavior of prostate cancer. This method is already used to detect …
assess the biological behavior of prostate cancer. This method is already used to detect …
Preoperative evaluation of prostate cancer by PSMA-68Ga PET-CT: correlation with prostate MRI and histopathological findings
CES Stasiak, A Cardillo, SA Almeida, D Herchenhorn… - inis.iaea.org
[en] This retrospective study evaluates the accuracy of preoperative PET-CT with PSMA-68
Ga in detecting and staging prostate carcinoma, compared to prostate magnetic resonance …
Ga in detecting and staging prostate carcinoma, compared to prostate magnetic resonance …
Comparison of findings on 68Ga-PSMA PET/CT and mpMRI for initial detection and staging of Prostate Cancer–single institutional experience
DK Gauthaman, K Luthra - 2023 - Soc Nuclear Med
P816 Introduction: In suspected cases of Prostate cancer, including men presenting with
prostatomegaly with lower urinary tract symptoms or abnormal raised serum prostate …
prostatomegaly with lower urinary tract symptoms or abnormal raised serum prostate …
68Ga-PSMA-11 PET/CT in newly diagnosed prostate adenocarcinoma
N Ergül, BY Güneş, U Yücetaş, MG Toktaş… - Clinical nuclear …, 2018 - journals.lww.com
Materials and Methods A total of 78 patients with biopsy-proven PCa who were referred for
68 Ga-PSMA-11 PET/CT for primary staging were retrospectively analyzed. The patients …
68 Ga-PSMA-11 PET/CT for primary staging were retrospectively analyzed. The patients …
Impact of 68Ga-PSMA PET/CT on the radiotherapeutic approach to prostate cancer in comparison to CT: a retrospective analysis
NS Schmidt-Hegemann, C Eze, M Li… - Journal of Nuclear …, 2019 - Soc Nuclear Med
68Ga-prostate-specific membrane antigen PET/CT (68Ga-PSMA PET/CT) offers
unprecedented accuracy for staging of primary, persistent, or recurrent prostate cancer …
unprecedented accuracy for staging of primary, persistent, or recurrent prostate cancer …
Comparison of 18F-PSMA-1007 PET/CT with 68Ga-PSMA-11 PET/CT for initial staging in intermediate and high-risk prostate cancer-A Pilot Study
K Chandekar, H Singh, R Kumar, A Bhattacharya… - 2021 - Soc Nuclear Med
1347 Introduction: 18 F-PSMA-1007 is a novel PET radio-tracer that offers several potential
advantages over 68 Ga-PSMA-ligands owing to its non-renal excretion (allowing better …
advantages over 68 Ga-PSMA-ligands owing to its non-renal excretion (allowing better …
Comparison of preoperative locoregional Ga‐68 PSMA‐11 PET‐CT and mp‐MRI results with postoperative histopathology of prostate cancer
B Yilmaz, R Turkay, Y Colakoglu, HF Baytekin… - The …, 2019 - Wiley Online Library
Background Conventional imaging modalities are inadequate to evaluate locoregional
extension of prostate cancer (PCa). The aim of the current retrospective study was to …
extension of prostate cancer (PCa). The aim of the current retrospective study was to …
Role of 68Ga-Labelled PSMA PET/CT in Assessment and Staging of Prostate Cancer
SR Ragheb, FS El-Din Mohammed… - QJM: An International …, 2023 - academic.oup.com
Background Prostate cancer (PCa) is the most common worldwide tumor in men with
increasing incidence. Aim of the Work The purpose of our study is to evaluate the potential …
increasing incidence. Aim of the Work The purpose of our study is to evaluate the potential …
[HTML][HTML] A prospective study on [68Ga]-PSMA PET/CT imaging in newly diagnosed Intermediate-and high-risk prostate Cancer
Objective (s): Prostate-specific membrane antigen (PSMA) ligand positron emission
tomography/computed tomography (PET/CT) is an emerging modality to detect metastatic …
tomography/computed tomography (PET/CT) is an emerging modality to detect metastatic …
Comparison of 68Ga-PSMA PET/CT and multiparametric MRI for staging of high-risk prostate cancer68Ga-PSMA PET and MRI in prostate cancer
S Tulsyan, CJ Das, M Tripathi, A Seth… - Nuclear medicine …, 2017 - journals.lww.com
Results The median age of the 36 patients included was 65 years (range: 44–80 years) and
the median prostate specific antigen was 94.3 ng/ml (range: 20–19005 ng/ml). Concordance …
the median prostate specific antigen was 94.3 ng/ml (range: 20–19005 ng/ml). Concordance …
Related searches
- pet ct prostate cancer
- pet ct histopathological findings
- pet ct psma 68ga
- histopathological findings prostate cancer
- psma 68ga prostate cancer
- psma 68ga histopathological findings
- computed tomography prostate cancer
- preoperative evaluation prostate cancer
- pet ct computed tomography
- computed tomography histopathological findings
- psma 68ga computed tomography
- high risk prostate cancer
- pet ct preoperative evaluation
- pet ct mp mri
- mp mri prostate cancer
- retrospective analysis prostate cancer